GS-5745 Completed Phase 1 Trials for Ulcerative Colitis (UC) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01831427Evaluating the Safety, Pharmacokinetics and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
NCT02209987Absolute Bioavailability, Safety, and Tolerability of Subcutaneous GS-5745 in Healthy Adults